@inproceedings{inproceedings, title  = {{Integrated Safety Update of Abrocitinib in 1014 Young Adult Patients Aged 18 to <40 Years With Moderate-to-Severe Atopic Dermatitis: Data From More Than 2250 Patient-Years With up to 4.5 Years of Exposure}},

 url = {{}},

 year = {{2025}},

 month = {{9}},

 author = {{Simpson E and Irvine AD and Silverberg JI and Gold LFS and Cork MJ and Deleuran M and Geng B and Lumpan C and Selfridge A and Fan H and Koppensteiner H}},

 volume = {{93}},

 journal = {{JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{AB234-AB234}},

 note = {{Accessed on 2025/10/28}}}